These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8259090)

  • 21. Pseudohypoaldosteronism: persistence of hyperaldosteronism and evidence for renal tubular and intestinal responsiveness to endogenous aldosterone.
    Postel-Vinay MC; Alberti GM; Ricour C; Limal JM; Rappaport R; Royer P
    J Clin Endocrinol Metab; 1974 Dec; 39(6):1038-44. PubMed ID: 4372243
    [No Abstract]   [Full Text] [Related]  

  • 22. Pseudohypoaldosteronism: evaluation of type I receptors by radioreceptor assay and by antireceptor antibodies.
    Armanini D; Karbowiak I; Zennaro CM; Zovato S; Pratesi C; De Lazzari P; Krozowski Z; Kuhnle U
    Steroids; 1995 Jan; 60(1):161-3. PubMed ID: 7792805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of effect of aldosterone on intracellular sodium and potassium in mononuclear leucocytes from patients with pseudohypoaldosteronism.
    Wehling M; Kuhnle U; Witzgall H; Weber PC; Armanini D
    Clin Endocrinol (Oxf); 1988 Jan; 28(1):67-74. PubMed ID: 3168302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pseudohypoaldosteronism].
    Arai K; Naruse K; Tanabe A; Naruse M; Demura H
    Nihon Rinsho; 1996 Mar; 54(3):812-8. PubMed ID: 8904242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult nephron-specific MR-deficient mice develop a severe renal PHA-1 phenotype.
    Canonica J; Sergi C; Maillard M; Klusonova P; Odermatt A; Koesters R; Loffing-Cueni D; Loffing J; Rossier B; Frateschi S; Hummler E
    Pflugers Arch; 2016 May; 468(5):895-908. PubMed ID: 26762397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aldosterone action, sodium channels and inherited disease.
    Fuller PJ; Lim-Tio S
    J Endocrinol; 1996 Mar; 148(3):387-90. PubMed ID: 8778216
    [No Abstract]   [Full Text] [Related]  

  • 27. Pseudohypoaldosteronism type 1: the index case revisited.
    Fuller PJ; Yao YZ; Komesaroff PA; Smith BJ; Zennaro MC
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):408-10. PubMed ID: 19788590
    [No Abstract]   [Full Text] [Related]  

  • 28. [Erythrocyte sodium transport in children with pseudohypoaldosteronism].
    Uchiyama M; Gomi T; Satokata I; Sakai K
    Rinsho Byori; 1988 Jun; 36(6):685-8. PubMed ID: 3210317
    [No Abstract]   [Full Text] [Related]  

  • 29. Impaired rapid mineralocorticoid action on free intracellular calcium in pseudohypoaldosteronism.
    Gamarra F; Simic-Schleicher G; Huber RM; Ulsenheimer A; Scriba PC; Kuhnle U; Wehling M
    J Clin Endocrinol Metab; 1997 Mar; 82(3):831-4. PubMed ID: 9062491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reducing αENaC expression in the kidney connecting tubule induces pseudohypoaldosteronism type 1 symptoms during K+ loading.
    Poulsen SB; Praetorius J; Damkier HH; Miller L; Nelson RD; Hummler E; Christensen BM
    Am J Physiol Renal Physiol; 2016 Feb; 310(4):F300-10. PubMed ID: 26582762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment for symptoms of pseudoaldosteronism].
    Shibata H; Ito H
    Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):805-10. PubMed ID: 17506322
    [No Abstract]   [Full Text] [Related]  

  • 32. Disorders of distal nephron function.
    Sebastian A; Hulter HN; Kurtz I; Maher T; Schambelan M
    Am J Med; 1982 Feb; 72(2):289-307. PubMed ID: 6277192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pseudohypoaldosteronism in infants with salt wasting syndrome. Two case reports].
    Szalecki M; Wójcik E; Domagała Z; Małunowicz E
    Pediatr Endocrinol Diabetes Metab; 2007; 13(1):33-6. PubMed ID: 17493404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A partial form of pseudohypoaldosteronism type I without renal sodium wasting.
    Ballauff A; Wendel U; Kupke I; Kuhnle U
    J Pediatr Endocrinol; 1994; 7(1):57-60. PubMed ID: 8186826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudohyperaldosteronism with renal tubular resistance to mineralocorticoid hormones.
    Rodriguez JA; Biglieri EG; Schambelan M
    Trans Assoc Am Physicians; 1981; 94():172-82. PubMed ID: 7046191
    [No Abstract]   [Full Text] [Related]  

  • 36. Potassium handling in health and disease: lessons from inherited tubulopathies.
    Landau D
    Pediatr Endocrinol Rev; 2004 Dec; 2(2):203-8. PubMed ID: 16429107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mineralocorticoid resistance.
    Geller DS
    Clin Endocrinol (Oxf); 2005 May; 62(5):513-20. PubMed ID: 15853818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudohypoaldosteronism type II: history, arguments, answers, and still some questions.
    Healy JK
    Hypertension; 2014 Apr; 63(4):648-54. PubMed ID: 24396028
    [No Abstract]   [Full Text] [Related]  

  • 39. [A case of mineralocorticoid-resistant renal hyperkalemia without sodium wasting (type II pseudohypoaldosteronism)].
    Ito K; Yamada K; Hasunuma K; Shiina T; Ebata T; Kikuno K; Yoshida S; Tamura Y; Yoshida S
    Nihon Naika Gakkai Zasshi; 1988 Mar; 77(3):425-9. PubMed ID: 3042897
    [No Abstract]   [Full Text] [Related]  

  • 40. Disturbances of Na/K balance: pseudohypoaldosteronism revisited.
    Bonny O; Rossier BC
    J Am Soc Nephrol; 2002 Sep; 13(9):2399-414. PubMed ID: 12191985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.